Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 2/20 | 0.38 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | NAMPT | P43490 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | L3MBTL4 | Q8NA19 | 1/20 | 0.30 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.30 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23560285 | 0.96 | HTR1B (0.35) | HTR1BKISS1REPHX1KDM4EALDH1A1 | |
| SCHEMBL23897093 | 0.93 | EPHX1 (0.37) | HTR1BKISS1REPHX1SPHK2SPHK1 | |
| SCHEMBL20648659 | 0.91 | EPHX1 (0.41) | HTR1BKISS1REPHX1SPHK2SPHK1 | |
| SCHEMBL9024417 | 0.85 | — | — | |
| Ammonia Solution, Strong SCHEMBL29051935 | 0.83 | KDM4E (0.32) | HTR1BKDM4ELMNATDP1HTR1D | |
| SCHEMBL20127154 | 0.81 | SPHK2 (0.33) | KDM4EALDH1A1SPHK2SPHK1NAMPT | |
| SCHEMBL23695892 | 0.81 | MEN1 (0.38) | HTR1BKDM4ELMNATDP1HTR1D | |
| SCHEMBL22848852 | 0.81 | MEN1 (0.38) | HTR1BKDM4ELMNATDP1HTR1D | |
| SCHEMBL20076246 | 0.81 | MEN1 (0.38) | HTR1BKDM4ELMNATDP1HTR1D | |
| SCHEMBL14870333 | 0.80 | HTR1B (0.34) | HTR1BEPHX1KDM4EALDH1A1NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024148060-A1 | MK2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2024-07-11 | — | — | WO | disclosed |
| WO-2023192586-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023192578-A1 | PROTEIN DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023076161-A1 | TYK2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| US-20230110180-A1 | CDK2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-04-13 | — | — | US | disclosed |
| WO-2023278759-A1 | MK2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2023-01-05 | — | — | WO | disclosed |
| WO-2022147465-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| WO-2022125790-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2022-06-16 | — | — | WO | disclosed |
| WO-2021127190-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021127278-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| US-7563489-B2 | piezoelectric ink jet printing; low jetting temperatures; curable epoxy-polyamide composite gellant and a reactive diluent; | XEROX CORPORATION (US) | 2009-07-21 | — | — | US | disclosed |
| US-7556844-B2 | Radiation curable photochromic inks | XEROX CORPORATION (US) | 2009-07-07 | — | — | US | disclosed |
| US-7531582-B2 | Radiation curable phase change inks containing curable epoxy-polyamide composite gellants | XEROX CORPORATION (US) | 2009-05-12 | — | — | US | disclosed |
| US-7459014-B2 | Radiation curable inks containing curable gelator additives | XEROX CORPORATION (US) | 2008-12-02 | — | — | US | disclosed |
| US-20080122914-A1 | RADIATION CURABLE PHASE CHANGE INKS CONTAINING CURABLE EPOXY-POLYAMIDE COMPOSITE GELLANTS | XEROX CORPORATION (US) | 2008-05-29 | — | — | US | disclosed |
| US-20070211110-A1 | RADIATION CURABLE PHOTOCHROMIC INKS | XEROX CORPORATION (US) | 2007-09-13 | — | — | US | disclosed |
| US-20070120924-A1 | Radiation curable phase change inks containing gellants | XEROX CORPORATION (US) | 2007-05-31 | — | — | US | disclosed |
| US-20070120921-A1 | Radiation curable phase change inks containing curable epoxy-polyamide composite gellants | XEROX CORPORATION (US) | 2007-05-31 | — | — | US | disclosed |
| US-5219480-A | ETHYLENE ALPHA-OLEFIN MANNICH BASE VISCOSITY INDEX IMPROVER/DISPERSANT ADDITIVES DERIVED FROM AMINO PHENOLS AND MONOSECONDARY AMINES | EXXON CHEMICAL PATENTS INC. (US) | 1993-06-15 | — | — | US | disclosed |
| EP-0357215-A1 | Ethylene alpha-olefin mannich base viscosity index improver/dispersant additives | EXXON CHEMICAL PATENTS INC. (US) | 1990-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230110180-A1 | CDK2 DEGRADERS AND USES THEREOF | CDK2, CDK20, CDK1 | HTR1B 3996/4885KISS1R 2423/4885EPHX1 2198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.